Back to Results
First PageMeta Content
Eli Lilly and Company / Lysergic acid diethylamide / Mind control / Novartis / Multidisciplinary Association for Psychedelic Studies / Lysergic acid / Play therapy / Behavior / Lysergamides / Entheogens / Chemistry


MAPS Study LDA-1 Switzerland
Add to Reading List

Document Date: 2013-09-15 22:15:40

Open Document

File Size: 2,69 MB

Share Result on Facebook

City

Santa Cruz / /

Company

Lipomed AG / /

Currency

pence / USD / CAD / /

/

/

IndustryTerm

light food / investigational product / /

MedicalCondition

primary disease / Bipolar-I Affective Disorder / advanced-stage life threatening diseases / e.g. brain metastasis / bipolar-I disorder / Anxiety Disorder / pain / primary psychotic disorder / rheumatoid diseases / metastatic cancer / breakthrough pain / diseases / Life-threatening Diseases / SCID / illness / another affective disorder / Dissociative Disorder / fatal illness / /

MedicalTreatment

psychotherapy / concomitant therapy / /

Organization

Study Center / Multidisciplinary Association for Psychedelic Studies / /

Person

Peter Gasser / Barbara Speich / Rick Doblin / /

/

Position

therapist / PRINCIPAL INVESTIGATOR / Co-investigator / outside therapist / /

Product

nicotine / /

ProvinceOrState

California / /

Technology

2013 FINAL CLINICAL STUDY REPORT Protocol / /

SocialTag